Get the Stockscreener App
4.51
0.27%
0.02
Precision Biosciences Inc stock is traded at $4.51, with a volume of 31,318.
It is up +0.27% in the last 24 hours and down -9.96% over the past month.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
See More
Previous Close:
$4.49
Open:
$4.5
24h Volume:
31,318
Relative Volume:
0.18
Market Cap:
$108.56M
Revenue:
$52.29M
Net Income/Loss:
$-73.52M
P/E Ratio:
-6.8333
EPS:
-0.66
Net Cash Flow:
$-100.45M
1W Performance:
-6.21%
1M Performance:
-9.96%
6M Performance:
-6.01%
1Y Performance:
-4.62%
1-Day Range:
$4.46
$4.57
1-Week Range:
$4.365
$5.04
52-Week Range:
$3.61
$8.82
Precision Biosciences Inc Stock (DTIL) Company Profile
Name
Precision Biosciences Inc
Sector
Industry
Phone
919-314-5512
Address
302 EAST PETTIGREW STREET, DURHAM, NC
Compare DTIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
4.51 | 108.08M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.00 | 115.75B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
779.44 | 80.71B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
410.08 | 52.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
853.53 | 52.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.21 | 37.29B | 447.02M | -1.18B | -906.14M | -6.1812 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Apr-30-24 | Initiated | Guggenheim | Buy |
| Jun-17-22 | Initiated | BMO Capital Markets | Outperform |
| Jun-09-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-27-20 | Resumed | BTIG Research | Buy |
| Apr-03-20 | Downgrade | Goldman | Buy → Neutral |
| Mar-05-20 | Initiated | Stifel | Buy |
| Feb-25-20 | Initiated | William Blair | Outperform |
| Aug-09-19 | Initiated | BTIG Research | Buy |
| Jul-16-19 | Initiated | H.C. Wainwright | Buy |
| Apr-22-19 | Initiated | Barclays | Overweight |
| Apr-22-19 | Initiated | Goldman | Buy |
| Apr-22-19 | Initiated | JP Morgan | Overweight |
| Apr-22-19 | Initiated | Jefferies | Buy |
View All
Precision Biosciences Inc Stock (DTIL) Latest News
What analysts say about Precision BioSciences Inc PBS0 stockInstitutional Buying Trends & Free Explosive Trading Growth - earlytimes.in
Will Precision BioSciences Inc. stock gain from government policies2025 Price Targets & Free Safe Capital Growth Stock Tips - Улправда
Will Precision BioSciences Inc. stock benefit from infrastructure spendingJuly 2025 Reactions & Smart Allocation Stock Tips - Улправда
Is Precision BioSciences Inc. (PBS0) stock a top hedge fund pickWeekly Profit Recap & Safe Investment Capital Preservation Plans - Улправда
Can Precision BioSciences Inc. stock reach $100 price targetJuly 2025 Sentiment & Community Trade Idea Sharing Platform - Bölüm Sonu Canavarı
How Precision BioSciences Inc. stock compares to industry benchmarksWeekly Investment Summary & Weekly Watchlist for Consistent Profits - ulpravda.ru
How Precision BioSciences Inc. stock reacts to global recession fearsNew Guidance & Technical Pattern Based Buy Signals - DonanımHaber
Market Recap: How Precision BioSciences Inc. stock reacts to global recession fears2025 Price Targets & Scalable Portfolio Growth Methods - DonanımHaber
How Precision BioSciences Inc. stock compares to market leadersJuly 2025 Drop Watch & Consistent Profit Trading Strategies - DonanımHaber
Will Precision BioSciences Inc. stock outperform Nasdaq indexIPO Watch & Daily Oversold Bounce Ideas - Улправда
Street Watch: Is Precision BioSciences Inc. (PBS0) stock a top hedge fund pick2025 Key Highlights & Daily Profit Maximizing Tips - ulpravda.ru
Precision BioSciences (NASDAQ:DTIL) Director Geno Germano Buys 3,000 Shares - MarketBeat
Insider Buying: Stanley Frankel Acquires Additional Shares of Pr - GuruFocus
Insider Buying: Precision BioSciences (NASDAQ:DTIL) Director Acquires $12,690.00 in Stock - MarketBeat
Financial Analysis: Precision BioSciences (NASDAQ:DTIL) & Upstream Bio (NASDAQ:UPB) - Defense World
Aug Summary: Can Precision BioSciences Inc stock hit analyst price targetsWeekly Trading Summary & Reliable Breakout Stock Forecasts - moha.gov.vn
Block Trades: Is Precision BioSciences Inc stock resilient to inflationBuy Signal & Comprehensive Market Scan Reports - BỘ NỘI VỤ
Precision BioSciences launches $75M stock and warrant offering - MSN
Is Precision BioSciences Inc. stock resilient to inflationJuly 2025 Decliners & Consistent Return Strategy Ideas - Newser
Can Precision BioSciences Inc. (PBS0) stock ride next bull market cycleWeekly Trading Summary & AI Enhanced Trading Signals - Newser
Precision Biosciences: Still Swinging And Finally Drawing Blood (NASDAQ:DTIL) - Seeking Alpha
Why Precision BioSciences Inc. (PBS0) stock is a strong buy callJuly 2025 Fed Impact & Growth Focused Entry Point Reports - Newser
How Precision BioSciences Inc. stock reacts to oil pricesQuarterly Profit Review & Reliable Breakout Forecasts - Newser
Is Precision BioSciences Inc. (PBS0) stock a contrarian opportunity - Newser
Precision BioSciences (DTIL) Stock Analysis Report | Financials & Insights - Benzinga
Will Precision BioSciences Inc. (PBS0) stock announce a stock split2025 Trading Volume Trends & Free Weekly Chart Analysis and Trade Guides - Newser
How Precision BioSciences Inc. (PBS0) stock compares with market leaders2025 Top Gainers & High Accuracy Buy Signal Tips - Newser
Why Precision BioSciences Inc. (PBS0) stock trades below fair valueLayoff News & Safe Entry Point Alerts - Newser
Precision BioSciences (NASDAQ:DTIL) Trading 4.9% HigherTime to Buy? - MarketBeat
Are Smart Investors Making the Right Decision? Precision Biosciences Inc (DTIL) - setenews.com
United StatesMintz Advises On Precision BioSciences, Inc.’s $75 Million Registered Direct Offering - Mondaq
H.C. Wainwright Keeps Their Buy Rating on Precision BioSciences (DTIL) - The Globe and Mail
Will Precision BioSciences Inc. stock return to pre crisis levelsLayoff News & Growth Focused Stock Reports - newser.com
Detecting price anomalies in Precision BioSciences Inc. with AIFed Meeting & Technical Confirmation Alerts - newser.com
How analysts rate Precision BioSciences Inc. stock todayMarket Sentiment Report & High Accuracy Swing Entry Alerts - newser.com
Will Precision BioSciences Inc. stock outperform Dow Jones indexAnalyst Downgrade & Weekly Top Gainers Alerts - newser.com
Will Precision BioSciences Inc. (PBS0) stock beat revenue estimates2025 Valuation Update & Safe Capital Growth Stock Tips - newser.com
Mintz Advises on Precision BioSciences, Inc.’s $75 Million Registered Direct Offering - Mintz
Precision BioSciences (DTIL) Price Target Decreased by 10.55% to 33.15 - MSN
Is Precision BioSciences Inc. stock dividend yield sustainableWeekly Risk Summary & Real-Time Chart Pattern Alerts - newser.com
Precision Biosciences Inc Stock (DTIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Precision Biosciences Inc Stock (DTIL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Frankel Stanley | Director |
Dec 16 '25 |
Buy |
4.70 |
2,700 |
12,690 |
19,478 |
| Brown Melinda | Director |
Dec 15 '25 |
Buy |
4.97 |
1,381 |
6,864 |
23,346 |
| Kelly John Alexander | Chief Financial Officer |
Nov 02 '25 |
Option Exercise |
0.00 |
3,605 |
0 |
78,601 |
| Kelly John Alexander | Chief Financial Officer |
Nov 03 '25 |
Sale |
6.49 |
1,303 |
8,456 |
77,298 |
| Scimeca Dario | General Counsel and Secretary |
Nov 02 '25 |
Option Exercise |
0.00 |
1,835 |
0 |
28,923 |
| Scimeca Dario | General Counsel and Secretary |
Nov 03 '25 |
Sale |
6.49 |
665 |
4,316 |
28,258 |
| Amoroso Michael | President and CEO |
Nov 02 '25 |
Option Exercise |
0.00 |
9,444 |
0 |
118,984 |
| Amoroso Michael | President and CEO |
Nov 03 '25 |
Sale |
6.49 |
3,409 |
22,124 |
115,575 |
0.08%
3.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):